Califf Highlights Plans to Improve Diversity in Clinical Trials

Clinical Trials Advisor
A A
The FDA plans to push for greater diversity in clinical trials, says Robert Califf, the presidential nominee to head the agency.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00